-
公开(公告)号:US20190167667A1
公开(公告)日:2019-06-06
申请号:US16020799
申请日:2018-06-27
Applicant: H. Lundbeck A/S
Inventor: Svend Treppendahl , Heidi Lopez de Diego
IPC: A61K31/495 , C07D295/096 , A61K9/08 , C07C59/08
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
-
公开(公告)号:US10034876B2
公开(公告)日:2018-07-31
申请号:US15271543
申请日:2016-09-21
Applicant: H. Lundbeck A/S
Inventor: Svend Treppendahl , Heidi Lopez de Diego
IPC: A61K31/495
CPC classification number: A61K31/495 , A61K9/08 , C07C59/08 , C07D295/096
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
-
3.Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine 有权
Title translation: 1- [2-(2,4-二甲基苯基硫烷基)苯基]哌嗪的盐的液体制剂公开(公告)号:US09475748B2
公开(公告)日:2016-10-25
申请号:US14567003
申请日:2014-12-11
Applicant: H. LUNDBECK A/S
Inventor: Svend Treppendahl , Heidi Lopez De Diego
IPC: A61K31/495 , A61K9/08 , C07D241/04 , C07C59/08 , C07D295/096
CPC classification number: A61K31/495 , A61K9/08 , C07C59/08 , C07D295/096
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
Abstract translation: 提供1- [2-(2,4-二甲基苯基硫基) - 苯基]哌嗪的乳酸加成盐的液体制剂。
-
公开(公告)号:US09382205B2
公开(公告)日:2016-07-05
申请号:US14553029
申请日:2014-11-25
Applicant: H. Lundbeck A/S
Inventor: Frans Therkelsen , Michael Harold Rock , Svend Treppendahl
IPC: C07D209/14 , C07D209/16
CPC classification number: C07D209/16 , C07D209/14
Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
-
5.
公开(公告)号:US08901318B2
公开(公告)日:2014-12-02
申请号:US13875623
申请日:2013-05-02
Applicant: H. Lundbeck A/S
Inventor: Frans Therkelsen , Michael Harold Rock , Svend Treppendahl
IPC: C07D209/16 , C07D209/14
CPC classification number: C07D209/16 , C07D209/14
Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
Abstract translation: 本文公开了制备药物活性剂及其药学上可接受的盐的方法。
-
6.
公开(公告)号:US20150080584A1
公开(公告)日:2015-03-19
申请号:US14553029
申请日:2014-11-25
Applicant: H. Lundbeck A/S
Inventor: Frans Therkelsen , Michael Harold Rock , Svend Treppendahl
IPC: C07D209/16
CPC classification number: C07D209/16 , C07D209/14
Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
Abstract translation: 本文公开了制备药物活性剂及其药学上可接受的盐的方法。
-
7.LIQUID FORMULATIONS OF SALTS OF 1-[2-(2,4-DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE 有权
Title translation: 1- [2-(2,4-二甲基苯基)苯基]哌嗪的液体液体制剂公开(公告)号:US20150094316A1
公开(公告)日:2015-04-02
申请号:US14567003
申请日:2014-12-11
Applicant: H. LUNDBECK A/S
Inventor: Svend Treppendahl , Heidi Lopez De Diego
IPC: C07C59/08 , C07D295/096
CPC classification number: A61K31/495 , A61K9/08 , C07C59/08 , C07D295/096
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine are provided
Abstract translation: 提供1- [2-(2,4-二甲基苯基硫烷基)苯基]哌嗪的乳酸加成盐的液体制剂
-
公开(公告)号:US20170224677A1
公开(公告)日:2017-08-10
申请号:US15271543
申请日:2016-09-21
Applicant: H. Lundbeck A/S
Inventor: Svend Treppendahl , Heidi Lopez de Diego
IPC: A61K31/495
CPC classification number: A61K31/495 , A61K9/08 , C07C59/08 , C07D295/096
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
-
公开(公告)号:US10857149B2
公开(公告)日:2020-12-08
申请号:US16020799
申请日:2018-06-27
Applicant: H. Lundbeck A/S
Inventor: Svend Treppendahl , Heidi Lopez de Diego
IPC: A61K31/495 , A61K9/08 , C07C59/08 , C07D295/096
Abstract: Liquid formulations of lactic acid addition salts of 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine are provided.
-
公开(公告)号:US20130245281A1
公开(公告)日:2013-09-19
申请号:US13875623
申请日:2013-05-02
Applicant: H. LUNDBECK A/S
Inventor: Frans Therkelsen , Michael Harold Rock , Svend Treppendahl
IPC: C07D209/14
CPC classification number: C07D209/16 , C07D209/14
Abstract: Disclosed herein are processes for the preparation of a pharmaceutically active agent and pharmaceutically acceptable salts thereof.
-
-
-
-
-
-
-
-
-